002622 皓宸医疗
2025/06 - 中期2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-6.163-9.073-18.774-35.874--
总资产报酬率 ROA (%)-1.615-2.485-5.951-14.984--
投入资产回报率 ROIC (%)-2.409-3.585-8.009-17.473--

边际利润分析
销售毛利率 (%)43.15948.32650.89941.48746.944
营业利润率 (%)-9.4540.433-5.740-14.788-41.001
息税前利润/营业总收入 (%)-3.6434.225-1.033-45.085-19.004
净利润/营业总收入 (%)-11.036-1.769-7.699-55.971-43.918

收益指标分析
经营活动净收益/利润总额(%)125.064-51.884-44.85847.06262.911
价值变动净收益/利润总额(%)-13.56339.887-34.913-26.55124.954
营业外收支净额/利润总额(%)7.549140.14319.72774.4651.342

偿债能力分析
流动比率 (X)0.2930.3340.3400.359--
速动比率 (X)0.2330.2770.2700.297--
资产负债率 (%)71.72570.41469.71565.223--
带息债务/全部投入资本 (%)45.31843.88344.15243.054--
股东权益/带息债务 (%)85.33590.02689.483105.441--
股东权益/负债合计 (%)35.98337.74940.41953.673--
利息保障倍数 (X)-0.5530.797-0.169-3.514-0.843

营运能力分析
应收账款周转天数 (天)19.11414.81713.83726.4770.000
存货周转天数 (天)52.51945.64556.12264.2370.000